(N-methyl-(11c))2-(4'-methylaminophenyl)-6-hydroxybenzothiazole
Pittsburgh Compound B is under investigation in clinical trial NCT01723553 (Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD).